Eli Lilly’s Acquisition of Scorpion Therapeutics
Overview of the Deal Acquirer: Eli Lilly and Company Target: Scorpion Therapeutics, Inc. Total Transaction Size: Up to $2.5 billion Upfront Payment: Approximately $1 billion
Overview of the Deal Acquirer: Eli Lilly and Company Target: Scorpion Therapeutics, Inc. Total Transaction Size: Up to $2.5 billion Upfront Payment: Approximately $1 billion
Overview of the Deal Acquirer: Carlyle Group Target: Baxter International’s Kidney Care Segment (to be named Vantive) Total Transaction Size: $3.8 billion Announcement Date: August
Overview of the Deal Acquirer: Carlyle Group Target: Baxter International’s Kidney Care Segment (to be named Vantive) Total Transaction Size: $3.8 billion Announcement Date: August
Overview of the Deal Acquirer: Carlyle Group Target: Baxter International’s Kidney Care Segment (to be named Vantive) Total Transaction Size: $3.8 billion Announcement Date: August
Overview of the Deal Acquirer: Johnson & Johnson Target: Intra-Cellular Therapies Total Transaction Size: $14.6 billion Price Per Share: $132 (40% premium to recent closing
Overview of the Deal Acquirer: GlaxoSmithKline (GSK) Target: IDRx, Inc. Total Transaction Size: Up to $1.15 billion Upfront Payment: $1 billion Potential Milestone Payments: $150
Overview of the Deal Acquirer: Chemist Warehouse Group Holdings Target: Sigma Healthcare Limited Total Transaction Size: Approximately A$8.8 billion (US$5.78 billion) Transaction Structure: Stock exchange
Overview of the Deal Acquirer: AdventHealth Target: ShorePoint Health System (including ShorePoint Health Port Charlotte and certain assets of ShorePoint Health Punta Gorda) Total Transaction
Overview of the Attempted Acquisition Acquirer: UnitedHealth Group (via its subsidiary, Optum) Target: Amedisys Inc. Proposed Transaction Size: $3.3 billion Offer Details: $101 per share
Overview of the Deal Acquirer: Sanford Health Target: Marshfield Clinic Health System Total Transaction Size: Not publicly disclosed Announcement Date: July 10, 2024 Merger Completion
Stay informed about the latest in healthcare M&A."
Sign-Up Form